
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mitochondrial quality control in kidney injury and repair
Chengyuan Tang, Juan Cai, Xiao-Ming Yin, et al.
Nature Reviews Nephrology (2020) Vol. 17, Iss. 5, pp. 299-318
Open Access | Times Cited: 331
Chengyuan Tang, Juan Cai, Xiao-Ming Yin, et al.
Nature Reviews Nephrology (2020) Vol. 17, Iss. 5, pp. 299-318
Open Access | Times Cited: 331
Showing 1-25 of 331 citing articles:
Mitochondria ROS and mitophagy in acute kidney injury
L. Joseph Su, Jiahao Zhang, Candelaria Gomez‐Manzano, et al.
Autophagy (2022) Vol. 19, Iss. 2, pp. 401-414
Open Access | Times Cited: 407
L. Joseph Su, Jiahao Zhang, Candelaria Gomez‐Manzano, et al.
Autophagy (2022) Vol. 19, Iss. 2, pp. 401-414
Open Access | Times Cited: 407
Cisplatin nephrotoxicity: new insights and therapeutic implications
Chengyuan Tang, Man J. Livingston, Robert L. Safirstein, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 53-72
Closed Access | Times Cited: 266
Chengyuan Tang, Man J. Livingston, Robert L. Safirstein, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 53-72
Closed Access | Times Cited: 266
The glomerular filtration barrier: a structural target for novel kidney therapies
Ilse S. Daehn, Jeremy S. Duffield
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 10, pp. 770-788
Open Access | Times Cited: 156
Ilse S. Daehn, Jeremy S. Duffield
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 10, pp. 770-788
Open Access | Times Cited: 156
Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity
Lin Wu, Litao Wang, Yuxin Du, et al.
Trends in Pharmacological Sciences (2022) Vol. 44, Iss. 1, pp. 34-49
Closed Access | Times Cited: 137
Lin Wu, Litao Wang, Yuxin Du, et al.
Trends in Pharmacological Sciences (2022) Vol. 44, Iss. 1, pp. 34-49
Closed Access | Times Cited: 137
Mechanisms of podocyte injury and implications for diabetic nephropathy
Federica Barutta, Stefania Bellini, Gabriella Gruden
Clinical Science (2022) Vol. 136, Iss. 7, pp. 493-520
Open Access | Times Cited: 116
Federica Barutta, Stefania Bellini, Gabriella Gruden
Clinical Science (2022) Vol. 136, Iss. 7, pp. 493-520
Open Access | Times Cited: 116
Oxidative Stress and Mitochondrial Dysfunction in Chronic Kidney Disease
Hsin‐Jung Ho, Hitoshi Shirakawa
Cells (2022) Vol. 12, Iss. 1, pp. 88-88
Open Access | Times Cited: 113
Hsin‐Jung Ho, Hitoshi Shirakawa
Cells (2022) Vol. 12, Iss. 1, pp. 88-88
Open Access | Times Cited: 113
Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS/HO-1/GPX4 axis
Qisheng Lin, Shu Li, Haijiao Jin, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 4, pp. 1192-1210
Open Access | Times Cited: 108
Qisheng Lin, Shu Li, Haijiao Jin, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 4, pp. 1192-1210
Open Access | Times Cited: 108
Transition of acute kidney injury to chronic kidney disease: role of metabolic reprogramming
Zijing Zhu, Jijia Hu, Zhaowei Chen, et al.
Metabolism (2022) Vol. 131, pp. 155194-155194
Closed Access | Times Cited: 99
Zijing Zhu, Jijia Hu, Zhaowei Chen, et al.
Metabolism (2022) Vol. 131, pp. 155194-155194
Closed Access | Times Cited: 99
Mitochondrial dysfunction in diabetic tubulopathy
Lan Yao, Xianhui Liang, Yingjin Qiao, et al.
Metabolism (2022) Vol. 131, pp. 155195-155195
Open Access | Times Cited: 97
Lan Yao, Xianhui Liang, Yingjin Qiao, et al.
Metabolism (2022) Vol. 131, pp. 155195-155195
Open Access | Times Cited: 97
The Pathophysiology of Sepsis-Associated AKI
Shuhei Kuwabara, Eibhlin Goggins, Mark D. Okusa
Clinical Journal of the American Society of Nephrology (2022) Vol. 17, Iss. 7, pp. 1050-1069
Open Access | Times Cited: 94
Shuhei Kuwabara, Eibhlin Goggins, Mark D. Okusa
Clinical Journal of the American Society of Nephrology (2022) Vol. 17, Iss. 7, pp. 1050-1069
Open Access | Times Cited: 94
Defective mitophagy in aged macrophages promotes mitochondrial DNA cytosolic leakage to activate STING signaling during liver sterile inflammation
Weizhe Zhong, Zhuqing Rao, Jian Xu, et al.
Aging Cell (2022) Vol. 21, Iss. 6
Open Access | Times Cited: 89
Weizhe Zhong, Zhuqing Rao, Jian Xu, et al.
Aging Cell (2022) Vol. 21, Iss. 6
Open Access | Times Cited: 89
Typhaneoside-Tetrahedral Framework Nucleic Acids System: Mitochondrial Recovery and Antioxidation for Acute Kidney Injury treatment
Ran Yan, Weitong Cui, Wenjuan Ma, et al.
ACS Nano (2023) Vol. 17, Iss. 9, pp. 8767-8781
Closed Access | Times Cited: 81
Ran Yan, Weitong Cui, Wenjuan Ma, et al.
ACS Nano (2023) Vol. 17, Iss. 9, pp. 8767-8781
Closed Access | Times Cited: 81
Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases
Qian Lu, Yanli Zhu, Chao Deng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 79
Qian Lu, Yanli Zhu, Chao Deng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 79
Nanocatalytic Biofunctional MOF Coating on Titanium Implants Promotes Osteoporotic Bone Regeneration through Cooperative Pro-osteoblastogenesis MSC Reprogramming
Maowen Chen, Dong Wang, Menghuan Li, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 15397-15412
Closed Access | Times Cited: 75
Maowen Chen, Dong Wang, Menghuan Li, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 15397-15412
Closed Access | Times Cited: 75
STING/ACSL4 axis-dependent ferroptosis and inflammation promote hypertension-associated chronic kidney disease
Li Gao, Jun‐Sheng Zhang, Tingting Yang, et al.
Molecular Therapy (2023) Vol. 31, Iss. 10, pp. 3084-3103
Open Access | Times Cited: 49
Li Gao, Jun‐Sheng Zhang, Tingting Yang, et al.
Molecular Therapy (2023) Vol. 31, Iss. 10, pp. 3084-3103
Open Access | Times Cited: 49
Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies
M. A. Darenskaya, С. И. Колесников, Н. В. Семенова, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12378-12378
Open Access | Times Cited: 45
M. A. Darenskaya, С. И. Колесников, Н. В. Семенова, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12378-12378
Open Access | Times Cited: 45
NOX4 is a potential therapeutic target in septic acute kidney injury by inhibiting mitochondrial dysfunction and inflammation
Jiameng Li, Liya Wang, Bo Wang, et al.
Theranostics (2023) Vol. 13, Iss. 9, pp. 2863-2878
Open Access | Times Cited: 43
Jiameng Li, Liya Wang, Bo Wang, et al.
Theranostics (2023) Vol. 13, Iss. 9, pp. 2863-2878
Open Access | Times Cited: 43
STING promotes ferroptosis through NCOA4-dependent ferritinophagy in acute kidney injury
Lini Jin, Binfeng Yu, Hongju Wang, et al.
Free Radical Biology and Medicine (2023) Vol. 208, pp. 348-360
Open Access | Times Cited: 43
Lini Jin, Binfeng Yu, Hongju Wang, et al.
Free Radical Biology and Medicine (2023) Vol. 208, pp. 348-360
Open Access | Times Cited: 43
Human umbilical cord mesenchymal stem cell exosome-derived miR-874-3p targeting RIPK1/PGAM5 attenuates kidney tubular epithelial cell damage
Yihang Yu, Meiling Chen, Qitong Guo, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 42
Yihang Yu, Meiling Chen, Qitong Guo, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 42
Mitochondrial quality control in human health and disease
Bohao Liu, Chen-Zhen Xu, Yi Liu, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 30
Bohao Liu, Chen-Zhen Xu, Yi Liu, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 30
Inhibition of Drp1- Fis1 interaction alleviates aberrant mitochondrial fragmentation and acute kidney injury
Zhixia Song, Yao Xia, Lang Shi, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 22
Zhixia Song, Yao Xia, Lang Shi, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 22
Mitochondrial metabolism and targeted treatment strategies in ischemic-induced acute kidney injury
Yongming Chen, Zixian Li, Hongyong Zhang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 21
Yongming Chen, Zixian Li, Hongyong Zhang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 21
Mitochondrial dysfunction and therapeutic perspectives in osteoporosis
Jialing Liu, Zhonghua Gao, Xiangjie Liu
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 19
Jialing Liu, Zhonghua Gao, Xiangjie Liu
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 19
Pathological mechanisms of kidney disease in ageing
Takeshi Yamamoto, Yoshitaka Isaka
Nature Reviews Nephrology (2024) Vol. 20, Iss. 9, pp. 603-615
Closed Access | Times Cited: 18
Takeshi Yamamoto, Yoshitaka Isaka
Nature Reviews Nephrology (2024) Vol. 20, Iss. 9, pp. 603-615
Closed Access | Times Cited: 18
Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease
Verónica Miguel, Isaac Shaw, Rafael Kramann
Nature Reviews Nephrology (2024)
Closed Access | Times Cited: 18
Verónica Miguel, Isaac Shaw, Rafael Kramann
Nature Reviews Nephrology (2024)
Closed Access | Times Cited: 18